Presentation TCT 2023 TCT 507: Association of CYP2C19*17 Carrier Status to Ischemic and Bleeding Outcomes Among Patients with Coronary Artery Disease Treated with Clopidogrel: a Meta-Analysis Presenter: Cole Clifford October 25, 2023
Presentation TCT 2023 TCT 380: The impact of obesity on antiplatelet monotherapy for secondary prevention after percutaneous coronary intervention: A sub-study of the HOST-EXAM trial Presenter: Minju Han October 25, 2023
Presentation TCT 2023 TCT 42: Does Heparin-induced thrombocytopenia affect in-hospital outcomes in patients presenting with ST-segment elevation myocardial infarction? A nationwide data analysis. Presenter: Purveshkumar Patel October 25, 2023
News Conference News TCT 2023 In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS Yael L. Maxwell October 25, 2023
News Conference News TCT 2023 LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI L.A. McKeown October 25, 2023
Presentation TCT 2023 TCT 457: Impact of Uninterrupted Versus Interrupted Oral Anticoagulation on 30-Day Outcomes in Patients Undergoing Coronary Angiography Presenter: Ting-Yu Wang October 25, 2023
News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
Presentation TCT 2023 The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration Presenter: Pieter Smits October 25, 2023
Presentation TCT 2023 TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium Presenter: Seong Huan Choi October 25, 2023
Presentation TCT 2023 TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention Presenter: Ji-Yeon Kim October 25, 2023
Presentation TCT 2023 TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation Presenter: Byeong-Keuk Kim October 25, 2023
Presentation TCT 2023 The Guidelines Need Updating: 3-6 Months of DAPT Is Sufficient Presenter: John Bittl October 25, 2023
Presentation TCT 2023 Longer Term DAPT Is What The Guidelines and Data Support Presenter: Mamas Mamas October 25, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
Presentation TCT 2023 DAPT Duration: Unsettled or Case Closed? Presenter: Duk-Woo Park October 24, 2023
Presentation TCT 2023 Standardizing The Language Around DAPT: An ARC Initiative Presenter: Davide Capodanno October 24, 2023
Presentation TCT 2023 Predicting Ischemic and Bleeding Risk in Patients after PCI on DAPT: An Individualized Patient Centered Machine Learning Model Presenter: Roxana Mehran October 24, 2023
Presentation TCT 2023 Standardizing the Language Around DAPT Post PCI: A Report From ARC With a Case Example Presenter: Dominick Angiolillo October 24, 2023
Presentation TCT 2023 Clopidogrel Monotherapy Following 1-month DAPT versus Aspirin Monotherapy Following 12-month DAPT in Patients Receiving PCI; Final 5-year Result of STOPDAPT-2 Presenter: Hirotoshi Watanabe October 23, 2023